References

European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries

10.1186/1532-429x-15-9 · 2013 · External reference

Cardiac magnetic resonance imaging using an open 0.35 T system

10.1097/01.rct.0000238010.64931.c6 · 2007 · External reference

Improving cardiovascular magnetic resonance access in low- and middle-income countries for cardiomyopathy assessment: rapid cardiovascular magnetic resonance

10.1093/eurheartj/ehac035 · 2022 · External reference

Unresolved reference

External reference

MRI-Derived Myocardial strain measures in normal subjects

10.1016/j.jcmg.2016.12.025 · 2018 · External reference

Myocardial strain imaging: theory, current practice, and the future

10.1016/j.jcmg.2024.07.011 · 2025 · External reference

Myocardial strain measurements derived from MR feature-tracking: influence of sex, age, field strength, and vendor

10.1016/j.jcmg.2023.05.019 · 2024 · External reference

Allergic-like hypersensitivity reactions to gadolinium-based contrast agents: an 8-year cohort study of 154 539 patients

10.1148/radiol.210545 · 2022 · External reference

Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis

10.1001/jamainternmed.2019.5284 · 2020 · External reference

Contraindications to magnetic resonance imaging: non-invasive imaging

10.1136/hrt.2007.125039 · 2008 · External reference

Nephrogenic systemic fibrosis in patients with advanced renal dysfunction following gadolinium-based contrast agents

10.1148/radiol.251794 · 2025 · External reference

Use of intravenous gadolinium-based contrast Media in patients with kidney disease: consensus statements from the American college of radiology and the National Kidney Foundation

10.1148/radiol.2020202903 · 2021 · External reference

Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve

10.1016/j.jacc.2007.04.053 · 2007 · External reference

2023 ESC guidelines for the management of acute coronary syndromes

10.1093/eurheartj/ehad191 · 2023 · External reference

The Canadian cardiovascular society classification of acute atherothrombotic myocardial infarction based on stages of tissue injury severity: an expert consensus statement

10.1016/j.cjca.2023.09.020 · 2024 · External reference

The use of periinfarct contrast-enhanced cardiac magnetic resonance imaging for the prediction of late postmyocardial infarction ventricular dysfunction

10.1016/j.ahj.2008.04.012 · 2008 · External reference

Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction

10.1161/circimaging.113.000702 · 2013 · External reference

Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction

10.1016/j.jacc.2014.06.1194 · 2014 · External reference

Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients

10.1016/j.jcmg.2014.05.010 · 2014 · External reference

Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance

10.1016/j.jacc.2010.02.033 · 2010 · External reference

Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study

10.1136/hrt.2007.122622 · 2008 · External reference

Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine

10.1186/1745-6215-15-249 · 2014 · External reference

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction

10.1056/nejm200011163432003 · 2000 · External reference

Incidence, outcomes, and predictors of ventricular thrombus after reperfused ST-segment-elevation myocardial infarction by using sequential cardiac MR imaging

10.1148/radiol.2017161898 · 2017 · External reference

Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction

10.1016/j.jacc.2006.05.078 · 2006 · External reference

Comparison of distinctive clinical and cardiac magnetic resonance features between ST elevation myocardial infarction patients with incomplete myocardial rupture and those with moderate to severe pericardial effusion

10.1177/2048872617719650 · 2019 · External reference

Cardiovascular magnetic resonance of left ventricular pseudoaneurysm

10.1136/hrt.2004.039768 · 2005 · External reference

True versus false left ventricular aneurysm: differentiation with MR imaging–initial experience

10.1148/radiol.2361031699 · 2005 · External reference

Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA)

10.1111/j.1365-2796.2012.02591.x · 2013 · External reference

2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

10.1093/eurheartj/ehaa575 · 2021 · External reference

Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions

10.1093/eurheartj/ehz332 · 2019 · External reference

Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA)

10.1093/ehjacc/zuab049 · 2021 · External reference

How late is too late? Influence of CMR timing in suspected MINOCA

10.1093/eurheartj/ehaf784.2159 · 2025 · External reference

Refining the role of CMR imaging in MINOCA

10.1016/j.jcmg.2021.03.024 · 2021 · External reference

Early comprehensive cardiovascular magnetic resonance imaging in patients with myocardial infarction with nonobstructive coronary arteries

10.1016/j.jcmg.2021.02.021 · 2021 · External reference

Myocardial infarction with nonobstructed coronary arteries: impact of CMR early after presentation

10.1016/j.jcmg.2016.11.010 · 2017 · External reference

Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries

10.1136/heartjnl-2019-316295 · 2020 · External reference

Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries

10.1016/j.jcmg.2018.12.023 · 2019 · External reference

Prognostic value of cardiac magnetic resonance imaging in acute coronary syndrome patients with troponin elevation and nonobstructive coronary arteries

10.1016/j.mayocp.2020.11.026 · 2021 · External reference

2024 ESC guidelines for the management of chronic coronary syndromes

10.1093/eurheartj/ehae177 · 2024 · External reference

Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance

10.1093/ehjci/jeab244 · 2022 · External reference

Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): board of trustees task force on standardized post-processing

10.1186/s12968-020-00610-6 · 2020 · External reference

Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week

10.1016/j.jacc.2021.08.022 · 2021 · External reference

Magnetic resonance perfusion or fractional flow reserve in coronary disease

10.1056/nejmoa1716734 · 2019 · External reference

Diagnostic and prognostic value of stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis

10.1001/jamacardio.2023.1290 · 2023 · External reference

Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update

10.1186/s12968-020-00607-1 · 2020 · External reference

Assessment of multivessel coronary artery disease using cardiovascular magnetic resonance pixelwise quantitative perfusion mapping

10.1016/j.jcmg.2020.06.041 · 2020 · External reference

Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease

10.1186/s12968-018-0435-1 · 2018 · External reference

Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance

10.1186/s12968-016-0318-2 · 2017 · External reference

Quantitative cardiovascular magnetic resonance myocardial perfusion mapping to assess hyperaemic response to adenosine stress

10.1093/ehjci/jeaa252 · 2021 · External reference

Stressed enough? Hyperaemic thresholds during quantitative cardiovascular magnetic resonance perfusion mapping

10.1093/ehjci/jeaa268 · 2021 · External reference

Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization

10.1161/01.cir.0000142045.22628.74 · 2004 · External reference

Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial

10.1016/s0140-6736(11)61335-4 · 2012 · External reference

MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. Single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial

10.1093/eurheartj/ehs022 · 2013 · External reference

Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial

10.1001/jama.2016.12680 · 2016 · External reference

Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study

10.1093/eurheartj/ehac286 · 2022 · External reference

The role of PET quantification in cardiovascular imaging

10.1007/s40336-014-0070-2 · 2014 · External reference

Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography

10.1161/01.cir.99.6.763 · 1999 · External reference

Evidence and applicability of stress cardiovascular magnetic resonance in detecting coronary artery disease: state of the art

10.3390/jcm10153279 · 2021 · External reference

2023 ESC guidelines for the management of cardiomyopathies

10.1093/eurheartj/ehad194 · 2023 · External reference

Cardiac magnetic resonance assessment of myocarditis

10.1161/circimaging.113.000416 · 2013 · External reference

Comparison of original and 2018 lake louise criteria for diagnosis of acute myocarditis: results of a validation cohort

10.1148/ryct.2019190010 · 2019 · External reference

Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document

10.1161/circheartfailure.120.007405 · 2020 · External reference

Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis

10.1016/j.jcmg.2021.11.017 · 2022 · External reference

Cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) imaging in the diagnosis and follow-up of patients with acute myocarditis and chronic inflammatory cardiomyopathy: a review paper with practical recommendations on behalf of the European Society of Cardiovascular Radiology (ESCR)

10.1007/s10554-023-02927-6 · 2023 · External reference

Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance

10.1161/circimaging.116.005242 · 2017 · External reference

Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis

10.1016/j.jcmg.2011.11.022 · 2012 · External reference

Cardiovascular magnetic resonance in myocarditis: a JACC white paper

10.1016/j.jacc.2009.02.007 · 2009 · External reference

Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases

10.1007/s10554-017-1063-9 · 2018 · External reference

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents

10.1186/1532-429x-16-36 · 2014 · External reference

Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-trial

10.1016/j.jacc.2016.02.013 · 2016 · External reference

Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis

10.1016/j.jacc.2019.08.1061 · 2019 · External reference

Predictors of mortality in patients with biopsy-proven viral myocarditis: 10-year outcome data

10.1161/jaha.119.015351 · 2020 · External reference

Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations

10.1016/j.jacc.2018.09.072 · 2018 · External reference

Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)

10.1093/eurheartj/ehy730 · 2019 · External reference

Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy

10.1161/circulationaha.121.058457 · 2022 · External reference

Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?

10.1136/heartjnl-2012-303418 · 2013 · External reference

Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations

10.1161/circulationaha.114.008554 · 2014 · External reference

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy

10.1016/j.jacc.2006.07.049 · 2006 · External reference

Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy

10.1001/jama.2013.1363 · 2013 · External reference

The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis

10.1016/j.jcmg.2018.03.006 · 2018 · External reference

Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes

10.1016/j.jcmg.2020.11.006 · 2021 · External reference

Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis

10.1016/j.jchf.2016.09.017 · 2017 · External reference

2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). with the special contribution of the Heart Failure Association (HFA) of the ESC

10.1002/ejhf.2333 · 2022 · External reference

Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients

10.1186/s12968-014-0081-1 · 2014 · External reference

2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)

10.1093/eurheartj/ehu284 · 2014 · External reference

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical practice guidelines

10.1161/cir.0000000000000937 · 2020 · External reference

Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy

10.1016/j.jcmg.2017.08.005 · 2017 · External reference

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging

10.1093/eurheartj/suab105 · 2021 · External reference

Comparison of maximal wall thickness in hypertrophic cardiomyopathy differs between magnetic resonance imaging and transthoracic echocardiography

10.1016/j.amjcard.2016.11.010 · 2017 · External reference

Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy

10.1016/j.amjcard.2023.11.003 · 2024 · External reference

Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy

10.1161/circulationaha.113.007094 · 2014 · External reference

Left ventricular apical aneurysms in hypertrophic cardiomyopathy: equivalent detection by magnetic resonance imaging and contrast echocardiography

10.1016/j.echo.2021.07.015 · 2021 · External reference

Clinical characteristics and prognostic importance of left ventricular apical aneurysms in hypertrophic cardiomyopathy

10.1016/j.jcmg.2022.03.029 · 2022 · External reference

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology working group on myocardial and pericardial diseases

10.1002/ejhf.2140 · 2021 · External reference

The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis

10.1186/s12968-017-0419-6 · 2018 · External reference

Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy

10.1007/s00392-022-02005-2 · 2023 · External reference

Magnetic resonance for differential diagnosis of left ventricular hypertrophy: diagnostic and prognostic implications

10.3390/jcm11030651 · 2022 · External reference

Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis

10.1080/13506129.2022.2064739 · 2022 · External reference

Cardiac magnetic resonance-derived extracellular volume mapping for the quantification of hepatic and splenic amyloid

10.1161/circimaging.121.012506 · 2021 · External reference

Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis

10.1161/circulationaha.115.016567 · 2015 · External reference

Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis

10.1016/j.jcmg.2020.03.010 · 2020 · External reference

Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment

10.1093/eurheartj/ehac363 · 2022 · External reference

T2 mapping in myocardial disease: a comprehensive review

10.1186/s12968-022-00866-0 · 2022 · External reference

Myocardial edema and prognosis in amyloidosis

10.1016/j.jacc.2018.03.536 · 2018 · External reference

How to image cardiac amyloidosis: a practical approach

10.1016/j.jcmg.2019.07.015 · 2020 · External reference

Proposed stages of myocardial phenotype development in fabry disease

10.1016/j.jcmg.2018.03.020 · 2019 · External reference

The role of cardiac imaging in the diagnosis and management of Anderson-Fabry Disease

10.1016/j.jcmg.2018.11.039 · 2019 · External reference

Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study

10.1136/hrt.2008.162800 · 2009 · External reference

Validated model for prediction of adverse cardiac outcome in patients with fabry disease

10.1016/j.jacc.2022.06.022 · 2022 · External reference

Management of cardiac sarcoidosis

10.1093/eurheartj/ehae356 · 2024 · External reference

Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear

10.1161/circep.113.000932 · 2014 · External reference

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

10.1093/eurheartj/ehad067 · 2023 · External reference

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis

10.1016/j.hrthm.2014.03.043 · 2014 · External reference

Japanese guidelines for cardiac sarcoidosis

10.17996/anc.17-00029 · 2017 · External reference

Spectrum of restrictive and infiltrative cardiomyopathies: part 1 of a 2-part series

10.1016/j.jacc.2018.01.016 · 2018 · External reference

Spectrum of restrictive and infiltrative cardiomyopathies: part 2 of a 2-part series

10.1016/j.jacc.2018.01.017 · 2018 · External reference

Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document in collaboration with the “working group on myocardial and pericardial diseases” of the European Society of Cardiology endorsed by the Indian academy of echocardiography

10.1093/ehjci/jex034 · 2017 · External reference

Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone

10.1016/s0002-9149(01)01978-6 · 2001 · External reference

Relationship of mild to moderate impairment of left ventricular ejection fraction with fatal ventricular arrhythmic events in cardiac sarcoidosis

10.1161/jaha.123.032047 · 2024 · External reference

Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study

10.1161/circulationaha.114.011522 · 2015 · External reference

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis

10.1186/s41824-021-00119-w · 2021 · External reference

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria

10.1093/eurheartj/ehq025 · 2010 · External reference

Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging

10.1093/ehjci/jew229 · 2017 · External reference

Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria

10.1016/j.ijcard.2020.06.005 · 2020 · External reference

Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European task force consensus report

10.1016/j.ijcard.2023.131447 · 2024 · External reference

Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology

10.1136/hrt.71.3.215 · 1994 · External reference

Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy

10.1016/j.ijcard.2013.04.208 · 2013 · External reference

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement

10.1093/eurheartj/ehv162 · 2015 · External reference

Prognostic role of cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy

10.1016/j.amjcard.2018.08.007 · 2018 · External reference

Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association

10.1161/cir.0b013e31829b2be6 · 2013 · External reference

Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations

10.1186/s12968-021-00827-z · 2022 · External reference

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

10.1186/1532-429x-10-42 · 2008 · External reference

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major

10.1161/circulationaha.109.874487 · 2009 · External reference

Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias

10.1111/bjh.17839 · 2022 · External reference

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

10.1053/euhj.2001.2822 · 2001 · External reference

On T2* magnetic resonance and cardiac iron

10.1161/circulationaha.110.007641 · 2011 · External reference

Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major

10.1136/hrt.2008.156497 · 2009 · External reference

Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications

10.1186/s12968-021-00765-w · 2021 · External reference

Iron overload cardiomyopathy in clinical practice

10.1161/circulationaha.111.050773 · 2011 · External reference

Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper

10.1093/ehjci/jeab253 · 2022 · External reference

2025 ESC/EACTS guidelines for the management of valvular heart disease

10.1093/eurheartj/ehaf194 · 2025 · External reference

Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation

10.1016/j.jcmg.2018.08.036 · 2019 · External reference

Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography

10.1080/10976640600604856 · 2006 · External reference

Comparison of severity of aortic regurgitation by cardiovascular magnetic resonance versus transthoracic echocardiography

10.1016/j.amjcard.2011.05.034 · 2011 · External reference

Influence of cardiac remodeling on clinical outcomes in patients with aortic regurgitation

10.1016/j.jacc.2023.03.001 · 2023 · External reference

Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome

10.1161/circulationaha.111.083600 · 2012 · External reference

Four-dimensional flow MRI: principles and cardiovascular applications

10.1148/rg.2019180091 · 2019 · External reference

The prognostic role of late gadolinium enhancement in aortic stenosis: a systematic review and meta-analysis

10.1016/j.jcmg.2019.03.029 · 2020 · External reference

Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis: the EVOLVED randomized clinical trial

10.1001/jama.2024.22730 · 2025 · External reference

Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance

10.1016/j.echo.2017.01.007 · 2017 · External reference

Multimodality imaging for the quantitative assessment of mitral regurgitation

10.21037/qims.2018.04.01 · 2018 · External reference

Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification

10.1161/circulationaha.115.017888 · 2016 · External reference

Replacement myocardial fibrosis in patients with mitral valve prolapse: relation to mitral regurgitation, ventricular remodeling, and arrhythmia

10.1161/circulationaha.120.050214 · 2021 · External reference

EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society

10.1093/europace/euac125 · 2022 · External reference

Mitral annular disjunction: normal or abnormal: it is all about location

10.1016/j.jcmg.2022.08.002 · 2022 · External reference

Prevalence of mitral Annulus disjunction and mitral valve prolapse in patients with idiopathic ventricular fibrillation

10.1161/jaha.121.025364 · 2022 · External reference

Importance of myocardial fibrosis in functional mitral regurgitation: from outcomes to decision-making

10.1016/j.jcmg.2020.10.027 · 2021 · External reference

T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse

10.1007/s00330-020-07140-w · 2021 · External reference

Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse

10.1186/s12968-021-00797-2 · 2021 · External reference

Usefulness of cardiac magnetic resonance imaging in aortic stenosis

10.1161/circimaging.119.010356 · 2020 · External reference

CMR in inflammatory vasculitis

10.1186/1532-429x-14-82 · 2012 · External reference

Detection of inflammatory aortopathies using multimodality imaging

10.1161/circimaging.118.008471 · 2019 · External reference

Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance

10.1016/j.echo.2014.11.015 · 2015 · External reference

Non-contrast-enhanced MR angiography of the thoracic aorta using cardiac and navigator-gated magnetization-prepared three-dimensional steady-state free precession

10.1002/jmri.21256 · 2008 · External reference

Unenhanced MR angiography of the thoracic aorta: initial clinical evaluation

10.2214/ajr.07.2997 · 2008 · External reference

Wall shear stress predicts aortic dilation in patients with bicuspid aortic valve

10.1016/j.jcmg.2021.09.023 · 2022 · External reference

False lumen rotational flow and aortic stiffness are associated with aortic growth rate in patients with chronic aortic dissection of the descending aorta: a 4D flow cardiovascular magnetic resonance study

10.1186/s12968-022-00852-6 · 2022 · External reference

4D flow cardiovascular magnetic resonance consensus statement: 2023 update

10.1186/s12968-023-00942-z · 2023 · External reference

Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease

10.1186/s12968-018-0451-1 · 2018 · External reference

2024 ESC guidelines for the management of peripheral arterial and aortic diseases

10.1093/eurheartj/ehae179 · 2024 · External reference

2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC)

10.1093/eurheartj/ehu281 · 2014 · External reference

Aortic dilatation and dissection in turner syndrome

10.1161/circulationaha.106.685487 · 2007 · External reference

Multimodality assessment of ascending aortic diameters: comparison of different measurement methods

10.1016/j.echo.2016.04.006 · 2016 · External reference

Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values

10.1161/circimaging.108.768911 · 2008 · External reference

Implications of asymmetry and valvular morphotype on echocardiographic measurements of the aortic root in bicuspid aortic valve

10.1016/j.echo.2018.08.004 · 2019 · External reference

False lumen flow assessment by magnetic resonance imaging and long-term outcomes in uncomplicated aortic dissection

10.1016/j.jacc.2022.04.017 · 2022 · External reference

2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical practice guidelines

10.1161/cir.0000000000001106 · 2022 · External reference

Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease? : MRI is the preferred method for evaluating right ventricular size and function in patients with congenital heart disease

10.1161/circimaging.113.000553 · 2014 · External reference

Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points

10.1161/circimaging.113.000932 · 2014 · External reference

2020 ESC guidelines for the management of adult congenital heart disease

10.1093/eurheartj/ehaa554 · 2021 · External reference

Arterial and venous blood flow: noninvasive quantitation with MR imaging

10.1148/radiology.185.3.1438767 · 1992 · External reference

Assessment of PDA shunt and systemic blood flow in newborns using cardiac MRI

10.1002/nbm.2927 · 2013 · External reference

The functional right ventricle and tricuspid regurgitation in Ebstein's anomaly

10.1016/j.ijcard.2011.12.081 · 2013 · External reference

Magnetic resonance imaging of constrictive pericardial disease

10.1016/0002-9149(85)90398-4 · 1985 · External reference

Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study

10.1161/circulationaha.111.026070 · 2011 · External reference

Quantitative pericardial delayed hyperenhancement informs clinical course in recurrent pericarditis

10.1016/j.jcmg.2016.10.020 · 2017 · External reference

Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis

10.1016/j.amjcard.2014.11.041 · 2015 · External reference

Value of CMR for the differential diagnosis of cardiac masses

10.1016/j.jcmg.2014.05.009 · 2014 · External reference

MR imaging of cardiac tumors and masses: a review of methods and clinical applications

10.1148/radiol.13121239 · 2013 · External reference

Cardiac masses, part 2: key imaging features for diagnosis and surgical planning

10.2214/ajr.11.6903 · 2011 · External reference

British Heart Rhythm S. Safe use of MRI in people with cardiac implantable electronic devices

10.1136/heartjnl-2015-308495 · 2015 · External reference

Access to MRI for patients with cardiac pacemakers and implantable cardioverter defibrillators

10.1136/openhrt-2021-001598 · 2021 · External reference

Making MRI available for patients with cardiac implantable electronic devices: growing need and barriers to change

10.1007/s00330-019-06449-5 · 2020 · External reference

Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices

10.1093/eurheartj/ehab350 · 2022 · External reference

Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices

10.1136/heartjnl-2022-320810 · 2024 · External reference

2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy

10.1093/eurheartj/ehab364 · 2021 · External reference